Scott M. Dehm, PhD, is a Professor in the Departments of Laboratory Medicine and Pathology and Urology at the University of Minnesota. He holds the Apogee Enterprises Chair in Cancer Research at the Masonic Cancer Center. Dr. Dehm received his BSc and his PhD in Biochemistry from the University of Saskatchewan. He completed his postdoctoral fellowship at the Mayo Clinic, where his research focused on mechanisms of androgen receptor activation in prostate cancer.
Dr. Dehm’s research laboratory focuses on the molecular mechanisms driving prostate cancer progression to therapy-resistant disease. His program studies changes in androgen receptor (AR) signaling that are driven by genetic and epigenetic alterations in prostate cancer cells. The goal of this work is to understand how cancer cells reactivate or bypass the AR pathway to evade drug therapies, enabling the development of new therapeutic strategies.
Dr. Dehm has a long history of service to the Endocrine Society. He served as the Basic Science Chair for the ENDO 2022 annual meeting and has been a member of the Annual Meeting Steering Committee. Additionally, he has served on the editorial boards for the Journal of the Endocrine Society and Hormones and Cancer, and has served as an abstract reviewer for the ENDO annual meeting.
